Apremilast’s Effect on CVD Risk Markers Evaluated in Study

'There has been a keen interest in understanding how psoriasis therapies impact cardiovascular risk,' said Joel Gelfand, MD, who presented the findings at the American Academy of Dermatology meeting.
Medscape Medical News
‘There has been a keen interest in understanding how psoriasis therapies impact cardiovascular risk,’ said Joel Gelfand, MD, who presented the findings at the American Academy of Dermatology meeting.
Medscape Medical News